Linked Life Data

18054408

Source:http://linkedlifedata.com/resource/pubmed/id/18054408

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-6-2
pubmed:abstractText
To evaluate the progression-free rate (PFR) at 3 months (13+/-1 weeks), antitumor response, time-to-event efficacy endpoints, and toxicity profile of plitidepsin administered as a 3-h continuous i.v. infusion at a dose of 5mg/m(2), every 2 weeks, to patients with chemotherapy pretreated advanced non-small cell lung cancer (NSCLC).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0169-5002
pubmed:author
pubmed:issnType
Print
pubmed:volume
60
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
374-80
pubmed:meshHeading
pubmed-meshheading:18054408-Adult, pubmed-meshheading:18054408-Aged, pubmed-meshheading:18054408-Anemia, pubmed-meshheading:18054408-Animals, pubmed-meshheading:18054408-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18054408-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:18054408-Depsipeptides, pubmed-meshheading:18054408-Disease Progression, pubmed-meshheading:18054408-Disease-Free Survival, pubmed-meshheading:18054408-Female, pubmed-meshheading:18054408-Humans, pubmed-meshheading:18054408-Infusions, Intravenous, pubmed-meshheading:18054408-Lung Neoplasms, pubmed-meshheading:18054408-Male, pubmed-meshheading:18054408-Middle Aged, pubmed-meshheading:18054408-Neoplasm Metastasis, pubmed-meshheading:18054408-Neoplasm Staging, pubmed-meshheading:18054408-Transaminases, pubmed-meshheading:18054408-Urochordata, pubmed-meshheading:18054408-gamma-Glutamyltransferase
pubmed:year
2008
pubmed:articleTitle
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.
pubmed:affiliation
Technische Universität, III. Medizinische Klinik, München, Germany. christian.peschel@lrz.tu-muenchen.de
pubmed:publicationType
Journal Article, Multicenter Study, Clinical Trial, Phase II